REGISTER now: Visser ai webinar - BEYOND THE HYPE: AI IN PATENT PROSECUTION
​

The UPC
Hub

Case reports, trends, insights and the litigators behind them, in one place.

Link copied
Download The UPC ReviewUPC Decisions

Ready for the UPC long before it opened.

We have run patent litigation across the UK and Germany for well over a decade. When the UPC opened in June 2023, our Uniphy team was ready from day one.

Our litigators and patent attorneys work as one team across UPC, UK and German proceedings.

Tap a year to explore

Established UK and German litigation practices

  • Built experience across electronics, telecoms, pharma and medtech
  • Integrated patent attorneys and litigators

Ran major cross-border actions across the UK and Germany

  • Handled FRAND, SEP and multi-jurisdictional disputes
  • Prepared for pan-European litigation long before the UPC existed

UPC goes live and we launch Uniphy

  • 40 UPC Representatives at launch
  • Seamless transition into UPC litigation from day one
Thought leadership

Our latest thinking on the UPC

See all thought leadership
Chinese companies13 Aug 2026
38%

of 2025 infringement actions at the UPC involved a Chinese party.

Chinese companies and the UPC: from enforcement targets to strategic users

The UPC's 2025 Annual Report shows Chinese parties playing a growing part in UPC litigation. We look at what that means.

Read the article →
SEP and FRAND7 Jun 2026

Choosing your SEP battleground: UPC, Germany or UK?

The key points SEP owners should weigh when choosing where to litigate.

Read the article →
Procedure21 Jan 2026

Confidentiality at the UPC: what litigants need to know

How sensitive information is protected, and when hearings can be private.

Read the article →
Biopharma13 Apr 2026

Biopharma strategy in 2026: lessons from 2025 on AI, M&A and the UPC

What biopharma teams can take from 2025 as they plan for 2026.

Read the article →
UK and the UPC26 Jun 2025

Unified Patent Court: the impact of Brexit

Could the UK take part in the UPC without rejoining the EU?

Read the article →
Outcomes

How UPC cases turn out

View more UPC statistics

The results of decided cases, with the median time the Court took. Hover or tab through the lists to explore.

Case reports

Read what the Court is deciding

Tags
No tags match that search.
Court
No courts match that search.
Sector
No sectors match that search.
0 of 100
Case Reports
Tag
Clear all
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Clear all
​
Tag
:
Tag

Darren Smyth's time as IPKat guest blogger comes to an end

02 July 2012
2012-07-02

Partner Darren Smyth's role as one of the IPKat's guest bloggers has come to a conclusion after six months.He will continue to post intermittently to the IPKat and more regularly to his Blog on EIP...

No items found.
No items found.
No items found.
​

IPO seeks views on helping SMEs get value from their IP

25 June 2012
2012-06-25

The UK Intellectual Property Office (IPO) is seeking comments on its proposals to offer support to SMEs to maximise the value of their IP assets.

No items found.
No items found.
No items found.
​

Apple v Samsung tablet design case latest

20 June 2012
2012-06-20

The litigation between Apple and Samsung about tablet computers and the alleged infringement of a (Community) Registered Design has been taking place in the High Court this week.

No items found.
No items found.
No items found.
​

23andMe's first patent causes a rift with customers

19 June 2012
2012-06-19

A recent IPKat post by Darren Smyth highlights the adverse consumer reaction to the issuance of a patent to a US company 23andMe which offers to sequence your genome and tell you about its...

No items found.
No items found.
No items found.
​

Referrals to the Enlarged Board of Appeal over procedural matters: a good use of EBA resources?

18 June 2012
2012-06-18

In a recent IPKat post, Darren Smyth ponders whether the Boards of Appeal of the European Patent Office should be referring cases to the Enlarged Board of Appeal on matters of procedural...

No items found.
No items found.
No items found.
​

Smith & Nephew v Convatec Technologies

15 June 2012
2012-06-15

Darren's Smyth's latest IPKat post concerns an action by Smith & Nephew to revoke a patent owned by Convatec Technologies for antimicrobial wound dressings impregnated with silver.

No items found.
No items found.
No items found.
​

'Tomato' patent case at the EPO results in second referral to the Enlarged Board

07 June 2012
2012-06-07

The European Patent Office (EPO) has referred a case relating to dried tomatoes to the Enlarged Board of Appeal for a second time.In his latest IPKat post, EIP's Darren Smyth discusses the most...

No items found.
No items found.
No items found.
​

Comic Enterprises Ltd v Twentieth Century Fox Film Corp [2012] EWPCC 13 – guidance on litigation before the Patents County Court

20 April 2012
2012-04-20

In ruling on an application to transfer a passing off and trade mark infringement action from the Patents County Court (PCC) to the High Court, HHJ Birss QC has provided further useful guidance for...

No items found.
No items found.
No items found.
​

Registered Community Designs: reasons for refusal

19 April 2012
2012-04-19

The OHIM has begun publishing information about Registered Community Design applications that have been refused.The designs themselves are not shown, but the grounds for refusal are now being made...

No items found.
No items found.
No items found.
​

Sanofi-Aventis patents on cancer drug Taxotere declared invalid

11 April 2012
2012-04-11

Two Sanofi-Aventis US patents for the cancer drug docetaxel, marketed as Taxotere, have been declared invalid by the Court of Appeals for the Federal Circuit.

No items found.
No items found.
No items found.
​

Samsung v Apple tablet battle hits the UK

05 April 2012
2012-04-05

The ongoing dispute between Apple and Samsung over Apple's Registered Community Designs for its iPad has now entered the UK courts.Darren Smyth's latest IPKat post relates to a decision of Mr Justice...

No items found.
No items found.
No items found.
​

Poland's law on cheap drugs declared contrary to EU law

03 April 2012
2012-04-03

A Polish law which allowed the sale of unapproved drugs which were cheaper than those approved has been declared contrary to EU law.The decision by the Court of Justice of the European Union is...

No items found.
No items found.
No items found.
​

Regeneron Pharmaceuticals Inc, Bayer Pharma AG v Genentech Inc

29 March 2012
2012-03-29

In today's IPKat, Darren Smyth analyses the decision in Regeneron Pharmaceuticals Inc, Bayer Pharma AG v Genentech Inc, a case which started as an action for a declaration of invalidity of...

No items found.
No items found.
No items found.
​

AstraZeneca patent revoked for obviousness

29 March 2012
2012-03-29

In a decision on 22 March in Teva and ors v AstraZeneca concerning a patent on a sustained release formulation of an anti-psychotic drug, Mr Justice Arnold revoked the patent due to obviousness.

No items found.
No items found.
No items found.
​

UK Government confirms Patent Box scheme

27 March 2012
2012-03-27

Chancellor George Osborne confirmed in his 2012 Budget that the proposed Patent Box scheme will go ahead.When fully phased in, the rate of Corporation Tax on profits attributed to patents will be 10%.

No items found.
No items found.
No items found.
​
No results found.
Please try updating your search criteria.
Speak to an expert

Meet our UPC team

Our team includes leading Attorneys-at-Law in Germany, technically skilled European patent attorneys, and highly reputed UK solicitors with experience in some of the largest European patent cases. With specialists based in Germany, Sweden (home to the UPC’s only regional division), and the UK (Europe’s largest litigation venue outside the UPC), we field formidable teams tailored to each case.

Our attorneys have worked together successfully for many years, enabling us to respond quickly and intelligently under the UPC’s tight timelines and new procedures. We offer clients a single point of contact for co-ordinated, cross-border litigation support.

‍

Christof Höhne
Partner, Rechtsanwalt, UPC Representative
Jerome Spaargaren
Partner, UK and European Patent Attorney, UPC Representative
Matthew Blaseby
Partner, UK and European Patent Attorney, UPC Representative
Michael Nielsen
Partner, UK and European Patent Attorney, UPC Representative
Darren Smyth
Partner, UK and European Patent Attorney, Design Attorney, UPC Representative
Monika Rai
Partner, UK and European Patent Attorney, Solicitor, UPC Representative
Isabelle Schaller
Partner, Rechtsanwältin, UPC Representative
Sebastian Fuchs
Partner, Rechtsanwalt, UPC Representative
Gareth Probert
Partner, UK and European Patent Attorney, UPC Representative
Heather McCann
Partner, UK and European Patent Attorney, UPC Representative
James Seymour
Partner, UK and European Patent Attorney, UPC Representative
Catherine Howell
Partner, Solicitor

联系我们

We’d love to hear from you. Whether you're exploring ways to protect, manage or maximise the value of your intellectual property, we are here to provide tailored support and strategic insight.

Please complete the form below and we will be in touch shortly.

感谢您！我们已收到您提交的信息。
哎呀！提交表单时出错了。请重试。
​
对 EIP 的职业感兴趣吗？

查看空缺职位